TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
LobSor Pharmaceuticals AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 8,330 | 27,318 | 18,867 |
Financial expenses | 9 | 75 | 176 |
Earnings before taxes | 24,509 | 34,782 | -20,289 |
EBITDA | 24,050 | 41,417 | -12,068 |
Total assets | 71,480 | 53,706 | 46,133 |
Current assets | 48,813 | 24,474 | 10,449 |
Current liabilities | 11,137 | 552 | 28,932 |
Equity capital | 60,342 | 53,154 | 15,636 |
- share capital | 33 | 36 | 37 |
Employees (average) | 3 | 3 | 1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 84.4% | 99.0% | 33.9% |
Turnover per employee | 2,777 | 9,106 | 18,867 |
Profit as a percentage of turnover | 294.2% | 127.3% | -107.5% |
Return on assets (ROA) | 34.3% | 64.9% | -43.6% |
Current ratio | 438.3% | 4433.7% | 36.1% |
Return on equity (ROE) | 40.6% | 65.4% | -129.8% |
Change turnover | -16,775 | 8,808 | 13,053 |
Change turnover % | -67% | 48% | 224% |
Chg. No. of employees | 0 | 2 | 0 |
Chg. No. of employees % | 0% | 200% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.